It is unsafe to consume alcohol with Dieta Plus 4.
CONSULT YOUR DOCTOR
Dieta Plus 4 may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
SAFE IF PRESCRIBED
Dieta Plus 4 is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Monitor the breastfed baby’s blood sugar during treatment with Dieta Plus 4
CAUTION
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
CAUTION
Dieta Plus 4 should be used with caution in patients with kidney disease. Dose adjustment of Dieta Plus 4 may be needed. Please consult your doctor.
Use of Dieta Plus 4 is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
CAUTION
Dieta Plus 4 should be used with caution in patients with liver disease. Dose adjustment of Dieta Plus 4 may be needed. Please consult your doctor.
Use of Dieta Plus 4 is not recommended in patients with severe liver disease.
Medicine Overview of Dieta Plus 4 30mg+4mg Tablet
Introduction
Dieta Plus 4 is a combination medicine that helps control blood sugar levels. This medicine is used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus. It helps in proper utilisation of insulin, thereby lowering the blood sugar levels. Dieta Plus 4 should be taken in the dose and duration as advised by your doctor. It must be taken with food to avoid stomach upset. If you miss a dose, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go...
... Show more
Uses of Dieta Plus 4
Type 2 diabetes mellitus
Side effects of Dieta Plus 4
Common
Hypoglycemia (low blood glucose level)
Nausea
Taste change
Diarrhea
Stomach pain
Headache
Edema (swelling)
Weight gain
Blurred vision
Bone fracture
Respiratory tract infection
How to use Dieta Plus 4
Use it as advised by your doctor or check the label for directions before use. Dieta Plus 4 is to be taken with food.
How Dieta Plus 4 works
Dieta Plus 4 is a combination of three antidiabetic medicines: Glimepiride, Metformin and Pioglitazone. They work by different mechanisms to provide better control of blood sugar when single or dual therapy is not effective. Glimepiride is a sulfonylurea which works by increasing the amount of insulin released by the pancreas in order to lower the blood glucose. Metformin is a biguanide. It works by lowering glucose production in the liver, delaying glucose absorption from intestines and increasing the body's sensitivity to insulin. Pioglitazone is a thiazolidinedione which further increases insulin sensitivity.
Quick Tips
Take it with food to lower your chance of having an upset stomach.
It may cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal.
Always carry some sugary food or fruit juice with you in case you experience hypoglycemic symptoms such as cold sweats, cool pale skin, tremor, and anxiety.
Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Brief Description
Indication
Type 2 DM
Adult Dose
Oral
Type 2 diabetes mellitus
Adult: 30 mg/2 mg, OR 30 mg/4 mg: Initially, 1 tab once daily then titrate gradually as needed.
Elderly: Should start w/ glimepiride 1 mg/day prior to initiating pioglitazone + glimepiride combination.
Hepatic Impairment
1 mg/day glimpiride PO prior to initiating glimepiride/pioglitazone; titrate conservatively to avoid hypoglycemia
Baseline ALT 2.5 xULN: Do not initiate
ALT >3 xULN or jaundice after initiating therapy: Discontinue
Renal Dose
Renal Impairment
CrCl 22 mL/min: 30 mg/2 mg or 30 mg/4 mg PO qDay initially
Contraindication
History of allergic reaction to sulfonamide derivative. Patient w/ established CHF (NYHA class III or IV). Not intended for treatment of type 1 DM or diabetic ketoacidosis.
Mode of Action
Pioglitazone, a thiazolidinedione, reduces blood glucose by improving target cell response to insulin w/o increasing pancreatic insulin secretion and is dependent on the presence of insulin for activity. Glimepiride, a sulfonylurea, stimulates insulin release from the pancreatic beta-cells. It also reduces glucose output from the liver and increases insulin sensitivity at peripheral target sites.
Precaution
Pioglitazone, like other thiazolidinediones, can cause dose-related fluid retention when used alone or in combination with other antidiabetic medications and is most common when is used in combination with insulin. Fluid retention may lead to or exacerbate congestive heart failure. Patients should be observed for signs and symptoms of congestive heart failure. If congestive heart failure develops, it should be managed according to current standards of care and discontinuation or dose reduction of must be considered.
Lactation: Not known if crosses into breast milk, discontinue drug or breastfeeding
Increased plasma levels w/ CYP2C8 inhibitors (e.g. gemfibrozil) and CYP2C9 inhibitors (e.g. fluconazole). Decreased plasma levels w/ CYP2C8 inducers (e.g. rifampicin). Colesevelam may reduce the max plasma concentration and total exposure of glimepiride. Concominant use w/ oral miconazole may lead to severe hypoglycaemia.
ব্যবসার জন্য পাইকারি দামে পণ্য কিনতে রেজিস্টেশন করুন
The information provided herein is accurate, updated and complete as per the best practices of the Company. Please note that this information should not be treated as a replacement for physical medical consultation or advice. We do not guarantee the accuracy and the completeness of the information so provided. The absence of any information and/or warning to any drug shall not be considered and assumed as an implied assurance of the Company. We do not take any responsibility for the consequences arising out of the aforementioned information and strongly recommend you for a physical consultation in case of any queries or doubts.